(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD

ACE-031 Peptide Vial 1mg

ACE-031 peptide is made from activin receptor IIB and immunoglobulin G1-Fc (IgG1-Fc). It binds to muscle proteins and inactivates myostatin. According to studies, it helps preserve strength and muscle mass in muscle-wasting diseases and neuromuscular issues.

£82.77£91.66

ACE-031 Peptide Vial 1mg New Zealand

ACE-031 is a protein-based therapy developed for treating Duchenne Muscular Dystrophy (DMD) and a soluble version of IIB (ActRIIB) that promotes muscle growth. According to studies, it accelerates the growth of muscles by binding to myostatin.

ACE-031 peptide was primarily designed for research objectives to treat muscle weakness and degeneration, a symptom of numerous neuromuscular illnesses, including muscular dystrophy.

ACE-031 works by hindering the action of specific proteins in the body, such as myostatin. Myostatin acts as natural ‘brakes’ to bound muscle growth and size. New Zealand Studies have shown the muscle grows larger and stronger when these substances are prohibited from working on muscle cells. ACE-031 is hoped to help maintain or enhance muscle in patients who have muscular dystrophy.

ACE-031 inhibits the action of particular proteins, such as myostatin, in the body. Myostatin is a natural ‘brake’ to restrict muscle growth and size. New Zealand Studies have revealed that when these chemicals are inhibited from acting on muscle cells, the muscle becomes larger and stronger. ACE-031 can potentially maintain or improve muscle function in patients with muscular dystrophy.

Since ACE-031 is a protein therapy, research indicates that it affects muscle growth via proteins that serve as on/off switches in the body. It is a recombinant fusion protein made by fusing a fragment of the human ActRIIB receptor with an antibody component that promotes muscle growth.

Muscles become stronger when the peptide decreases the signal that prevents muscle synthesis. It promotes muscle growth and strength by inhibiting a receptor that binds myostatin from interacting with an active type II receptor (ActRIIB) for research purposes only.

Benefits of Ace-031 New Zealand:

  • Could help increase lean body mass.
  • Research indicates that it may promote muscle development
  • Contributes to lowering leptin concentration
  • Possible factor in fat reduction
  • Studies have revealed Ace-031 can enhance alkaline phosphatase in the blood
  • Can help decrease collagen telopeptide
  • It may strengthen your bones, reducing their susceptibility to fractures and other ailments.

 

References:

https://pubmed.ncbi.nlm.nih.gov/27462804/

https://onlinelibrary.wiley.com/doi/10.1002/mus.23539

 

ALL PRODUCT INFORMATION AND ARTICLES ON THIS SITE ARE FOR EDUCATIONAL PURPOSES ONLY

DISCLAIMER: All products sold by PharmaGrade.Store are for research and laboratory use only. These products are not designed for use or consumption by humans or animals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such. By purchasing from our Website the buyer accepts and acknowledges the risks involved with handling of these products. All articles and product information provided on this Website are for informational and educational purposes only. Handling and use of these products should be restricted to suitably qualified professionals.

You may also like…